A detailed history of Ashfield Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 99,496 shares of PFE stock, worth $2.66 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
99,496
Previous 99,496 -0.0%
Holding current value
$2.66 Million
Previous $5.22 Million 16.54%
% of portfolio
0.37%
Previous 0.41%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $37,224 - $44,136
800 Added 0.81%
99,496 $5.22 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $47,305 - $58,617
-1,034 Reduced 1.04%
98,696 $5.11 Million
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $128,794 - $190,916
-3,117 Reduced 3.03%
99,730 $5.89 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $7,536 - $9,680
192 Added 0.19%
102,847 $4.42 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $14,076 - $15,946
392 Added 0.38%
102,655 $4.02 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $8,104 - $9,140
242 Added 0.24%
102,263 $3.71 Million
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $26,776 - $34,048
800 Added 0.79%
102,021 $3.76 Million
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $14,573 - $17,097
-459 Reduced 0.45%
101,221 $3.72 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $277,405 - $336,533
9,210 Added 9.96%
101,680 $3.33 Million
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $12,866 - $18,383
476 Added 0.52%
92,470 $3.02 Million
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $238,274 - $270,411
-7,238 Reduced 7.29%
91,994 $3.6 Million
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $26,551 - $29,811
-718 Reduced 0.72%
99,232 $4.3 Million
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $187 - $206
-5 Reduced 0.01%
99,950 $4.25 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $274,214 - $312,634
7,128 Added 7.68%
99,955 $4.36 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $18,958 - $22,995
-550 Reduced 0.59%
92,827 $4.09 Million
Q2 2018

Jul 26, 2018

BUY
$32.98 - $35.16 $17,050 - $18,177
517 Added 0.56%
93,377 $3.39 Million
Q1 2018

May 02, 2018

BUY
$31.91 - $37.02 $17,805 - $20,657
558 Added 0.6%
92,860 $3.3 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $71,109 - $75,450
-2,138 Reduced 2.26%
92,302 $3.34 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $44,175 - $48,663
1,425 Added 1.53%
94,440 $3.37 Million
Q2 2017

Aug 14, 2017

BUY
N/A
93,015
93,015 $3.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ashfield Capital Partners, LLC Portfolio

Follow Ashfield Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.